Physician profile
Keith E Kortman
NPI 1942276332
$2,160.62
in general payments reported to CMS, 2019-2025
12 companies · $171 in 2025
The $171 reported for 2025 was more than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $517 · 2020: $792 · 2021: $301 · 2022: $380 · 2025: $171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $171.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $170.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $574.23 | 2020-2021 | |
| Stryker Corporation | $310.84 | 2019-2021 | |
| W. L. Gore & Associates, INC. | $236.16 | 2022 | |
| Hitachi Healthcare Americas Corp. | $216.85 | 2019 | |
| Terumo Medical Corporation | $188.35 | 2019-2020 | |
| Si-Bone, INC. | $170.65 | 2025 | |
| Surmodics, INC. | $143.75 | 2022 | |
| Inari Medical, INC. | $125.75 | 2021 | |
| Cook Medical LLC | $120.21 | 2019 | |
| Canon Medical Systems USA, INC. | $41.99 | 2019 | |
| Covidien Lp | $18.29 | 2019 | |
| Medtronic, INC. | $13.55 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Kortman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.